Leading experts in hematopoietic cell transplantation (HCT) and cellular and gene therapy will gather in Honolulu from Feb. 12-15 to share the latest scientific advancements and emerging technology in the field. Scientific Organizing Committee Co-Chairs Marie Bleakley, MD, PhD, MMsc, and Melody Smith, MD, MS, offer insights into the program lineup.
A full day of programming is dedicated to the tailored treatments that are required to care for this uniquely vulnerable patient population, explains Michael Verneris, MD, in a preview of the Pediatric Track agenda.
Track Chair Nicole Daukshus, PharmD, BCOP, outlines what attendees can expect from this programming, including presentations on immunotherapy, gene therapy, and transplant complications.
The Advanced Practice Provider Track at the 2025 Tandem Meetings includes one day featuring topics of interest to all providers and one day of dedicated, parallel sessions for providers of pediatric care and of adult care, explains Track Chair Chelsea Honstain, NP.
Track organizers have made a concerted effort to include more information and diverse approaches to various topics so that the sessions are applicable to attendees from multiple settings, not only larger transplant centers. Lenise Taylor, RN, MN, AOCNS, details what attendees can expect.
This year’s recipient of the APP Lifetime Achievement Award, Sameeya Ahmed-Winston, CPNP, CPHON, BMTCN, shares insights and her outlook on being an advanced practice provider in the field of transplantation.
Linde Morsink, MD, this year’s recipient of the Editorial Award for Clinical Research, previews her lecture on using post transplantation cyclophosphamide (PTCy) in combination with a short duration of immune suppression to improve outcomes in older patients diagnosed with myeloid malignancies.
Discover novel clinical findings and scientific breakthroughs while connecting with more than 5,000 professionals in the field and engaging with industry representatives.